| __timestamp | MorphoSys AG | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 9689000 | 1802274 |
| Thursday, January 1, 2015 | 10431000 | 2512761 |
| Friday, January 1, 2016 | 9618000 | 2894488 |
| Sunday, January 1, 2017 | 12348000 | 8096274 |
| Monday, January 1, 2018 | 28310241 | 7985229 |
| Tuesday, January 1, 2019 | 59336147 | 8994597 |
| Wednesday, January 1, 2020 | 159145941 | 29772000 |
| Friday, January 1, 2021 | 199800000 | 33907000 |
| Saturday, January 1, 2022 | 90225000 | 26579000 |
| Sunday, January 1, 2023 | 92538000 | 49868547 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, MorphoSys AG and Verona Pharma plc have taken different paths in optimizing these costs. From 2014 to 2023, MorphoSys AG's SG&A expenses surged by over 850%, peaking in 2021. In contrast, Verona Pharma plc maintained a more conservative growth, with expenses increasing by approximately 2,670% during the same period.
MorphoSys AG's expenses reached their zenith in 2021, reflecting strategic investments in growth. Meanwhile, Verona Pharma plc's expenses saw a significant jump in 2023, indicating a potential shift in strategy. This data highlights the contrasting approaches of these two companies in managing operational costs, offering valuable insights for investors and industry analysts alike.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or MorphoSys AG
Teva Pharmaceutical Industries Limited and Verona Pharma plc: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Insmed Incorporated and MorphoSys AG
SG&A Efficiency Analysis: Comparing Catalent, Inc. and Verona Pharma plc
Operational Costs Compared: SG&A Analysis of Grifols, S.A. and MorphoSys AG
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs MorphoSys AG Trends and Insights
Alkermes plc and MorphoSys AG: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Verona Pharma plc vs Ultragenyx Pharmaceutical Inc.
Operational Costs Compared: SG&A Analysis of Verona Pharma plc and Protagonist Therapeutics, Inc.
Verona Pharma plc vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Verona Pharma plc vs Travere Therapeutics, Inc.
Who Optimizes SG&A Costs Better? MorphoSys AG or Taro Pharmaceutical Industries Ltd.